J. David Enloe Jr. - 15 Dec 2021 Form 4 Insider Report for Recro Pharma, Inc.

Role
Chief Executive Officer, Director
Signature
By: Ryan D. Lake, attorney- in-fact
Issuer symbol
N/A
Transactions as of
15 Dec 2021
Net transactions value
+$993
Form type
4
Filing time
17 Dec 2021, 18:37:47 UTC
Previous filing
16 Nov 2021
Next filing
19 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $993 +617 +0.4% $1.61 154,157 15 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.